Evidence map›Paper›PMID 26631233›Full record

ArticleOrphanet journal of rare diseases2015

Prevalence, incidence, and age at diagnosis in Marfan Syndrome.

Kristian A Groth, Hanne Hove, Kasper Kyhl, Lars Folkestad, Mette Gaustadnes, Niels Vejlstrup, Kirstine Stochholm, John R Østergaard, Niels H Andersen, Claus H Gravholt

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 199 citations in OpenAlex.

  1. Pooled it
  2. Prevalence of Obstructive Sleep Apnea in Joint Hypermobility Syndrome: A Systematic Review and Meta-Analysis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2019
    Pooled it
  3. Article
  4. Article
  5. Genetic Associations with Pectus Excavatum: A Systematic Review.Current issues in molecular biology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Kristian A GrothDepartment of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark. kristian.groth@ki.au.dk.
Hanne HoveDepartment of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, DK-2100, Copenhagen, Denmark.
Kasper KyhlDepartment of Cardiology, Rigshospitalet, DK-2100, Copenhagen, Denmark.
Lars FolkestadDepartment of Endocrinology, Odense University Hospital, DK-5000, Odense C, Denmark.
Mette GaustadnesDepartment of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus N, Denmark.
Niels VejlstrupDepartment of Cardiology, Rigshospitalet, DK-2100, Copenhagen, Denmark.
Kirstine StochholmCentre for Rare Diseases, Department of Paediatrics, Aarhus University Hospital, DK-8200, Aarhus N, Denmark.
John R ØstergaardCentre for Rare Diseases, Department of Paediatrics, Aarhus University Hospital, DK-8200, Aarhus N, Denmark.
Niels H AndersenDepartment of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark.
Claus H GravholtDepartment of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus N, Denmark.
Aarhus University Hospital · DKRigshospitalet · DKCopenhagen University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarfan syndrome is a genetic disorder with considerable morbidity and mortality. Presently, clinicians use the 2010 revised Ghent nosology, which includes optional genetic sequencing of the FBN1 gene, to diagnose patients. So far, only a few studies based on older diagnostic criteria have reported a wide range of prevalence and incidence. Our aim was to study prevalence, incidence, and age at diagnosis in patients with Marfan syndrome.

methodUsing unique Danish patient-registries, we identified all possible Marfan syndrome patients recorded by the Danish healthcare system (1977-2014). Following, we confirmed or rejected the diagnosis according to the 2010 revised Ghent nosology.

resultsWe identified a total of 1628 persons with possible Marfan syndrome. We confirmed the diagnosis in 412, whereof 46 were deceased, yielding a maximum prevalence of 6.5/100,000 at the end of 2014. The annual median incidence was 0.19/100,000 (range: 0.0-0.7) which increased significantly with an incidence rate ratio of 1.03 (95% CI: 1.02-1.04, p < 0.001). We found a median age at diagnose of 19.0 years (range: 0.0-74). The age at diagnosis increased during the study period, uninfluenced by the changes in diagnostic criteria. We found no gender differences.

conclusionThe increasing prevalence of Marfan syndrome during the study period is possibly due to build-up of a registry. Since early diagnosis is essential in preventing aortic events, diagnosing Marfan syndrome remains a task for both pediatricians and physicians caring for adults.

Indexed as

RegistriesAdipokinesAdolescentAdultAgedAge of OnsetChildChild, PreschoolDenmarkFemaleFibrillin-1FibrillinsHumansIncidenceInfantInfant, NewbornAdipokinesFBN1 protein, humanFibrillin-1FibrillinsMicrofilament Proteins

Identifiers

PMID26631233
PMCPMC4668669
OpenAlexW2187927065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.